欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/H/8065/001
药品名称ACT-HIB
活性成分
    • haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid 10.0 µg/0,5ml
剂型Powder and solvent for solution for injection
上市许可持有人Dummy PR created for all purely national authorised products included in the WS procedure FR/H/xxxx/WS/359 MA Holder: SANOFI PASTEUR
参考成员国 - 产品名称France (FR)
ACT-HIB
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
许可日期2023/05/26
最近更新日期2023/06/23
药物ATC编码
    • J07AG01 haemophilus influenzae B, purified antigen conjugated
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase